ECLIPSE TMR LASER TRIAL EXPANSION TO BE OVERSEEN BY NEW PRES./CEO MUELLER
This article was originally published in The Gray Sheet
Executive Summary
Eclipse Surgical Technologies expects clinical trials for use of its holmium laser in transmyocardial revascularization (TMR) to be in "full swing" in the second quarter of this year.